Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. - Wikidata - awgldk - TriplyDB

Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities.

Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities.

http://www.wikidata.org/entity/Q33620499

about

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkers Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team Informatics methods to enable sharing of quantitative imaging research data Imaging biomarker roadmap for cancer studies Scattering by single physically large and weak scatterers in the beam of a single-element transducer.Volumetric CT-based segmentation of NSCLC using 3D-Slicer Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer.Methods and challenges in quantitative imaging biomarker development Clinical utility of quantitative imaging.A catalyzing phantom for reproducible dynamic conversion of hyperpolarized [1-¹³C]-pyruvate.Variability in assessing treatment response: metastatic colorectal cancer as a paradigm.Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.Robust Radiomics feature quantification using semiautomatic volumetric segmentation.Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability Consistency of breast density measured from the same women in four different MR scanners.Special Section Guest Editorial:Radiomics and Imaging Genomics: Quantitative Imaging for Precision Medicine Quantitative imaging biomarker ontology (QIBO) for knowledge representation of biomedical imaging biomarkers Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC.Challenges and opportunities for imaging journals: emerging from the shadows.Applications of imaging technology in radiation research.P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker.Towards Generation, Management, and Exploration of Combined Radiomics and Pathomics Datasets for Cancer Research.Dynamic contrast-enhanced MRI for oncology drug development.Choline-to-N-acetyl aspartate and lipids-lactate-to-creatine ratios together with age assemble a significant Cox's proportional-hazards regression model for prediction of survival in high-grade gliomas.Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients Accelerating drug development for Alzheimer's disease through the use of data standards Statistical characterization of noise for spatial standardization of CT scans: Enabling comparison with multiple kernels and doses.Autocalibration method for non-stationary CT bias correction.Acute stroke: a comparison of different CT perfusion algorithms and validation of ischaemic lesions by follow-up imaging.Novel approaches to improve prostate cancer diagnosis and management in early-stage disease.How reliable are ADC measurements? A phantom and clinical study of cervical lymph nodes.Automated Modular Magnetic Resonance Imaging Clinical Decision Support System (MIROR): An Application in Pediatric Cancer Diagnosis.

P2860

Q23760721-1ECA94F0-1DE9-41C8-BD40-5142D18DD041 Q26825076-A08946A4-D3CA-44DD-8A69-A7839AB285C5 Q28595520-51B99866-20D0-42F9-B8AA-90068A6EBDFF Q28727266-30642BF9-5BEE-42F2-90E0-985DED466D89 Q30242020-90705D6A-6854-4492-8211-6CE0CFB1F583 Q30389715-48E6024A-FFDA-467D-A452-613A19E7B17D Q34392512-3CB42BB6-D9B5-4ECF-96F8-663009B0BF4B Q34488635-0EBAE2C4-82A9-48CC-90EF-96471376BE87 Q34648114-36FC901E-D72B-42EC-8720-94769BB8C049 Q34656915-3A547F2C-9139-402A-A3F4-C61077CB6FE6 Q34970773-D0E81383-AE5A-4B7E-B08A-FBAF4CCA2337 Q35110520-FE275C38-21AF-4014-BA68-7F48618ED0D7 Q35110740-3CA8FE42-2022-417F-9F42-8EF71B70889A Q35206996-9A338C13-7E19-4DE1-AF6F-EF368C8443AE Q35945509-5DF1B0B4-2B69-4CFD-B4FF-CB4B12C0429C Q36139231-02604CF3-AAB2-448C-99DC-03E2163E15CF Q36509010-D1994375-E838-426A-8AE1-CDE302BF4484 Q36993012-74581307-CE23-42F2-AE96-4EA00A39399E Q37266991-3F7BB9E7-0D2A-4936-9ADF-93423270667D Q37918973-3B2831E9-04F6-46EF-AF96-E49557BD711C Q37991769-D54CF52D-C8E2-407D-96A4-A8574245F40B Q38177850-85D3FDB9-167A-49D5-948A-CBF3048ACDBB Q38621184-57252A3C-7B31-4910-AC24-C3E740F6A28B Q38725827-D6A84F0C-34CA-427E-BFF7-1B4531C18A6A Q40582144-12774857-781A-41D6-9FB0-8D311A4A5E7E Q42318810-8CAF09EF-BCAC-44D1-8A30-22C4D83A462C Q42532688-01231FD7-8D52-4DA1-B6C3-649719A94404 Q42655623-5BBBDB85-4A6B-4967-8876-F5BC6B176E85 Q47132829-704498A6-E916-41BB-ADF0-08198A4FD625 Q47243839-C901540D-F58D-4590-B5D4-6731FE09470F Q48466066-C4720A0C-5442-4E43-94B6-289E1C164968 Q51176148-374ECC07-9304-4CE1-958E-DADB0BDDB0DF Q52687653-22543E36-7590-40B6-8B20-10CF2ADDB10D Q55346991-7E7DF402-01BB-4B8F-A9FC-20301DEE3F5B

P2860

Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities.

http://www.wikidata.org/entity/Q33620499

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Quantitative imaging test appr ...... lated but distinct activities.

@ast

Quantitative imaging test appr ...... lated but distinct activities.

@en

type

label

Quantitative imaging test appr ...... lated but distinct activities.

@ast

Quantitative imaging test appr ...... lated but distinct activities.

@en

prefLabel

Quantitative imaging test appr ...... lated but distinct activities.

@ast

Quantitative imaging test appr ...... lated but distinct activities.

@en

P1433

Q33620499-0A465CA4-B28B-489B-9A93-FEB94ADB8E43

P1476

Q33620499-2CF52398-BCD5-45BA-A0C9-A647C89F5782

P2093

Q33620499-04F95C17-3B77-497D-B4FE-C14FD0F10D39

Q33620499-0E95833B-0409-493C-8082-3797CA7A7616

Q33620499-18298BE6-AAFC-4C1D-BA4A-1CA8A32D3D78

Q33620499-2A68CDF8-B915-49E9-A5BC-55A45968B474

Q33620499-3778AAA7-A5A8-46A4-93FC-7B8B3108A61F

Q33620499-3CE55E6B-104C-4CAD-8F46-CF820869BF1F

Q33620499-3D5A79A9-F80A-456F-B97B-91B43130158E

Q33620499-4812E8EF-570E-4CF3-8D8A-34912EF53209

Q33620499-51D0412F-A9C4-4202-95DD-7D2792E7FD1A

Q33620499-5A98742F-0B62-40A7-BC04-72956C06F0F3

P2860

Q33620499-0863D7EC-0741-4EA3-A4CC-26F9D4AD24B7

Q33620499-0948A2C0-46E6-46A5-B084-0EFF47530BE5

Q33620499-27C91CDF-DCF6-45AD-BBFA-BC3F3BA2A5EA

Q33620499-6581FAF6-BF41-4D46-8411-A3282C49860F

Q33620499-6CE898C0-8786-4295-862A-B6E55BBCE793

Q33620499-8A32672E-9989-428D-BCCB-AACB66086698

Q33620499-8C126F49-A5EA-47ED-A85C-3B26A2F205FD

Q33620499-944A7968-954D-4DE4-A9A7-7563844D9128

Q33620499-9D5370B0-BF48-4ED2-9510-686AA34639AA

Q33620499-BF5FD69C-1863-416C-8028-ADEDC7DA2D08

P304

Q33620499-0EFF6818-691E-4F27-80E1-7269093B66BC

P31

Q33620499-C6EB2471-6FFA-44E6-B696-C1E1C2C61E1D

P356

Q33620499-050D477A-B1AF-4FEA-A7E5-58AE08CB7991

P407

Q33620499-663DA65C-48A7-4AAD-860A-1966333553D8

P433

Q33620499-B49A6F94-025D-473E-8BB2-26F10242CF22

P478

Q33620499-9D81BD96-1D2D-4242-A3CE-AD8DEC6FEFE9

P50

Q33620499-15AB500C-C24D-4399-8EC5-43F03516078C

Q33620499-8BC86055-81C1-4FDE-84C0-0E9F107DB7E4

Q33620499-C4025A38-6E9F-4288-B2FF-3E4992F3BD9E

Q33620499-CFF70526-51D8-4E65-9DC3-E82960A5EA33

P577

Q33620499-63A18C4D-7E66-4B1B-9369-FBB16A502E05

P5875

Q33620499-13B1B4C4-4B41-4F2F-83D6-89F6D144735E

P698

Q33620499-BEE1FA22-6662-4116-9493-4F9B1D2083CF

P921

Q33620499-D6464D54-DE84-4EB2-BFEA-385C9ACC09CA

P932

Q33620499-40C3AE29-423C-4A63-BB6A-039480A09056

P356

RADIOL.10100800

P1433

P1476

Quantitative imaging test appr ...... lated but distinct activities.

@en

P2093

A Gregory Sorensen

http://www.w3.org/2001/XMLSchema#string

Barry A Siegel

http://www.w3.org/2001/XMLSchema#string

Bernard Bendriem

http://www.w3.org/2001/XMLSchema#string

Brian Zimmerman

http://www.w3.org/2001/XMLSchema#string

Cathy Elsinger

http://www.w3.org/2001/XMLSchema#string

Colin G Miller

http://www.w3.org/2001/XMLSchema#string

Constantine Gatsonis

http://www.w3.org/2001/XMLSchema#string

Daniel C Sullivan

http://www.w3.org/2001/XMLSchema#string

David Gustafson

http://www.w3.org/2001/XMLSchema#string

David Raunig

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients

Validation of novel imaging methodologies for use as cancer clinical trial end-points

Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources

The FDA critical path initiative and its influence on new drug development.

Strategic paths for biomarker qualification.

Process map proposal for the validation of genomic biomarkers.

Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.

Questions and answers about the Pilot Process for Biomarker Qualification at the FDA.

Working together to enhance the efficiency of medical product development.

P304

875-884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.10100800

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

259

http://www.w3.org/2001/XMLSchema#string

P50

Ronald Boellaard

Andrew J Buckler

Pamela S. Douglas

P577

2011-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49839704

http://www.w3.org/2001/XMLSchema#string

P698

21325035

http://www.w3.org/2001/XMLSchema#string

P921

P932

5410955

http://www.w3.org/2001/XMLSchema#string